Testicular biopsies in men with testicular microlithiasis and additional risk factors for cancer: A case series

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Testicular biopsies in men with testicular microlithiasis and additional risk factors for cancer : A case series. / Frandsen, Rasmus Hassing; Durukan, Emil; von Rohden, Elena; Jensen, Christian Fuglesang S.; Thamsborg, Andreas Key Milan; Azawi, Nessn; Fode, Mikkel.

In: Andrology, 2024.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Frandsen, RH, Durukan, E, von Rohden, E, Jensen, CFS, Thamsborg, AKM, Azawi, N & Fode, M 2024, 'Testicular biopsies in men with testicular microlithiasis and additional risk factors for cancer: A case series', Andrology. https://doi.org/10.1111/andr.13610

APA

Frandsen, R. H., Durukan, E., von Rohden, E., Jensen, C. F. S., Thamsborg, A. K. M., Azawi, N., & Fode, M. (2024). Testicular biopsies in men with testicular microlithiasis and additional risk factors for cancer: A case series. Andrology. https://doi.org/10.1111/andr.13610

Vancouver

Frandsen RH, Durukan E, von Rohden E, Jensen CFS, Thamsborg AKM, Azawi N et al. Testicular biopsies in men with testicular microlithiasis and additional risk factors for cancer: A case series. Andrology. 2024. https://doi.org/10.1111/andr.13610

Author

Frandsen, Rasmus Hassing ; Durukan, Emil ; von Rohden, Elena ; Jensen, Christian Fuglesang S. ; Thamsborg, Andreas Key Milan ; Azawi, Nessn ; Fode, Mikkel. / Testicular biopsies in men with testicular microlithiasis and additional risk factors for cancer : A case series. In: Andrology. 2024.

Bibtex

@article{08003e15796d4356be481f55fa4f002f,
title = "Testicular biopsies in men with testicular microlithiasis and additional risk factors for cancer: A case series",
abstract = "Background: Testicular microlithiasis is the presence of small calcifications in the testicular parenchyma. The association between testicular microlithiasis and germ cell neoplasia in situ, a precursor to testicular cancer, is still unclear. Objectives: To determine the incidence of germ cell neoplasia in situ in men with testicular microlithiasis and evaluate the indication for testicular biopsy according to risk factors in the form of male infertility/reduced semen quality, testicular atrophy, and history of cryptorchidism. Materials and methods: This retrospective case series included all patients diagnosed with testicular microlithiasis who underwent testicular biopsies at three hospitals in Denmark between 2007 and 2021. The medical records of 167 patients were reviewed, and data on patient demographics, testicular microlithiasis characteristics, risk factors, histological findings, and treatments were collected. The main outcome measure was the incidence of germ cell neoplasia in situ in relation to each risk factor. The data were analyzed using descriptive statistics. Logistic regression was used to examine the odds ratio of germ cell neoplasia in situ in patients with testicular microlithiasis and testicular atrophy. Results: Germ cell neoplasia in situ was found in 13 out of 167 patients (7.8% [95% confidence interval: 4.3, 13.2]). Eleven of these had testicular atrophy resulting in a significantly higher incidence in this group than other risk factors (odds ratio 9.36 [95% confidence interval: 2.41, 61.88]; p = 0.004). Discussion: The study comprises the largest cohort to date of men who have undergone testicular biopsies because of testicular microlithiasis and additional risk factors. Limitations include its retrospective design, and relatively low absolute numbers of patients with germ cell neoplasia in situ on biopsies. Conclusion: This study found that men with testicular microlithiasis and testicular atrophy are at an increased risk of germ cell neoplasia in situ. Additionally, our results indicate that biopsies should be considered in men with a combination of subfertility and bilateral testicular microlithiasis. Our findings do not support testicular biopsies for men with testicular microlithiasis and other risk factors.",
keywords = "germ cell neoplasms, microlithiasis, testicular biopsy, testicular carcinoma in situ, testicular microcalcification, testicular neoplasms",
author = "Frandsen, {Rasmus Hassing} and Emil Durukan and {von Rohden}, Elena and Jensen, {Christian Fuglesang S.} and Thamsborg, {Andreas Key Milan} and Nessn Azawi and Mikkel Fode",
note = "Publisher Copyright: {\textcopyright} 2024 The Authors. Andrology published by Wiley Periodicals LLC on behalf of American Society of Andrology and European Academy of Andrology.",
year = "2024",
doi = "10.1111/andr.13610",
language = "English",
journal = "Journal of Andrology",
issn = "2047-2919",
publisher = "Wiley-Blackwell",

}

RIS

TY - JOUR

T1 - Testicular biopsies in men with testicular microlithiasis and additional risk factors for cancer

T2 - A case series

AU - Frandsen, Rasmus Hassing

AU - Durukan, Emil

AU - von Rohden, Elena

AU - Jensen, Christian Fuglesang S.

AU - Thamsborg, Andreas Key Milan

AU - Azawi, Nessn

AU - Fode, Mikkel

N1 - Publisher Copyright: © 2024 The Authors. Andrology published by Wiley Periodicals LLC on behalf of American Society of Andrology and European Academy of Andrology.

PY - 2024

Y1 - 2024

N2 - Background: Testicular microlithiasis is the presence of small calcifications in the testicular parenchyma. The association between testicular microlithiasis and germ cell neoplasia in situ, a precursor to testicular cancer, is still unclear. Objectives: To determine the incidence of germ cell neoplasia in situ in men with testicular microlithiasis and evaluate the indication for testicular biopsy according to risk factors in the form of male infertility/reduced semen quality, testicular atrophy, and history of cryptorchidism. Materials and methods: This retrospective case series included all patients diagnosed with testicular microlithiasis who underwent testicular biopsies at three hospitals in Denmark between 2007 and 2021. The medical records of 167 patients were reviewed, and data on patient demographics, testicular microlithiasis characteristics, risk factors, histological findings, and treatments were collected. The main outcome measure was the incidence of germ cell neoplasia in situ in relation to each risk factor. The data were analyzed using descriptive statistics. Logistic regression was used to examine the odds ratio of germ cell neoplasia in situ in patients with testicular microlithiasis and testicular atrophy. Results: Germ cell neoplasia in situ was found in 13 out of 167 patients (7.8% [95% confidence interval: 4.3, 13.2]). Eleven of these had testicular atrophy resulting in a significantly higher incidence in this group than other risk factors (odds ratio 9.36 [95% confidence interval: 2.41, 61.88]; p = 0.004). Discussion: The study comprises the largest cohort to date of men who have undergone testicular biopsies because of testicular microlithiasis and additional risk factors. Limitations include its retrospective design, and relatively low absolute numbers of patients with germ cell neoplasia in situ on biopsies. Conclusion: This study found that men with testicular microlithiasis and testicular atrophy are at an increased risk of germ cell neoplasia in situ. Additionally, our results indicate that biopsies should be considered in men with a combination of subfertility and bilateral testicular microlithiasis. Our findings do not support testicular biopsies for men with testicular microlithiasis and other risk factors.

AB - Background: Testicular microlithiasis is the presence of small calcifications in the testicular parenchyma. The association between testicular microlithiasis and germ cell neoplasia in situ, a precursor to testicular cancer, is still unclear. Objectives: To determine the incidence of germ cell neoplasia in situ in men with testicular microlithiasis and evaluate the indication for testicular biopsy according to risk factors in the form of male infertility/reduced semen quality, testicular atrophy, and history of cryptorchidism. Materials and methods: This retrospective case series included all patients diagnosed with testicular microlithiasis who underwent testicular biopsies at three hospitals in Denmark between 2007 and 2021. The medical records of 167 patients were reviewed, and data on patient demographics, testicular microlithiasis characteristics, risk factors, histological findings, and treatments were collected. The main outcome measure was the incidence of germ cell neoplasia in situ in relation to each risk factor. The data were analyzed using descriptive statistics. Logistic regression was used to examine the odds ratio of germ cell neoplasia in situ in patients with testicular microlithiasis and testicular atrophy. Results: Germ cell neoplasia in situ was found in 13 out of 167 patients (7.8% [95% confidence interval: 4.3, 13.2]). Eleven of these had testicular atrophy resulting in a significantly higher incidence in this group than other risk factors (odds ratio 9.36 [95% confidence interval: 2.41, 61.88]; p = 0.004). Discussion: The study comprises the largest cohort to date of men who have undergone testicular biopsies because of testicular microlithiasis and additional risk factors. Limitations include its retrospective design, and relatively low absolute numbers of patients with germ cell neoplasia in situ on biopsies. Conclusion: This study found that men with testicular microlithiasis and testicular atrophy are at an increased risk of germ cell neoplasia in situ. Additionally, our results indicate that biopsies should be considered in men with a combination of subfertility and bilateral testicular microlithiasis. Our findings do not support testicular biopsies for men with testicular microlithiasis and other risk factors.

KW - germ cell neoplasms

KW - microlithiasis

KW - testicular biopsy

KW - testicular carcinoma in situ

KW - testicular microcalcification

KW - testicular neoplasms

U2 - 10.1111/andr.13610

DO - 10.1111/andr.13610

M3 - Journal article

C2 - 38375999

AN - SCOPUS:85186199037

JO - Journal of Andrology

JF - Journal of Andrology

SN - 2047-2919

ER -

ID: 384951724